Clinitech Laboratory Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2025 ,inter alia, to consider and approve the Un-Audited Financial ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Clinitech Laboratory Ltd has informed BSE that its Board of Directors will meet on Wednesday, November 12, 2025, at 11:30 AM via video conferencing. The key agenda items are: (1) to consider and approve the Un-Audited Financial Results along with the Limited Review Report for the half year ended September 30, 2025, and (2) to consider and approve the formation of a subsidiary company. The intimation is filed under SEBI LODR Regulations 29 and 30. The company recently converted from a private limited entity, indicated by the '(formerly known as Clinitech Laboratory Private Limited)' tag.
Retail investors should watch for two key outcomes from this meeting: the H1 FY26 financial results (which will reveal half-yearly performance trends) and the decision on forming a new subsidiary, which could signal a strategic expansion or restructuring move. The actual numbers and subsidiary details are not yet disclosed.